BCM
NVRO

BlueCrest Capital Management’s NEVRO CORP. NVRO Stock Holding History

BlueCrest Capital Management’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-9,549
Closed -$711K – 1124
2017
Q2 		$711K Sell
9,549
-1,551
-14% -$124K 0.03% 526
2017
Q1 		$1.04M Buy
+11,100
New +$1.01M 0.05% 314

Other funds holding NVRO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BlueCrest Capital Management's NVRO Position: Q3 2017 in Review

BlueCrest Capital Management sold out of NEVRO CORP. (NVRO) in Q3 2017, closing a stake of 9,549 shares — an estimated $711K sold.

BlueCrest Capital Management first reported a position in NVRO in Q1 2017 and held it in 2 quarters. The position peaked at $1.04M in Q1 2017. 183 funds tracked by Wall St. Rank hold NVRO as of Q3 2017.

  • BlueCrest Capital Management reported no remaining NEVRO CORP. position as of Q3 2017 after selling out during the quarter.
  • BlueCrest Capital Management sold 9,549 NEVRO CORP. shares in Q3 2017, an estimated $711K.
  • BlueCrest Capital Management first reported a position in NEVRO CORP. in Q1 2017 and held it in 2 quarters.
  • BlueCrest Capital Management's NEVRO CORP. position peaked at $1.04M in Q1 2017.
  • 183 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2017.

Based on BlueCrest Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.